LEVOTHYROXINE SODIUM | A207588 | WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Highest NADAC/Unit
$0.0849
per ea
Lowest NADAC/Unit
$0.0468
per ea
Brand NDCs
0
Generic NDCs
12
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00480872298LEVOTHYROXINE 200 MCG TABLET | $0.0849 | EA | Generic | — | 2026-10-21 |
| 00480872210LEVOTHYROXINE 200 MCG TABLET | $0.0849 | EA | Generic | — | 2026-10-21 |
| 00480871810LEVOTHYROXINE 175 MCG TABLET | $0.0748 | EA | Generic | — | 2026-10-21 |
| 00480871898LEVOTHYROXINE 175 MCG TABLET | $0.0748 | EA | Generic | — | 2026-10-21 |
| 00480871010LEVOTHYROXINE 137 MCG TABLET | $0.0633 | EA | Generic | — | 2026-10-21 |
| 00480871098LEVOTHYROXINE 137 MCG TABLET | $0.0633 | EA | Generic | — | 2026-10-21 |
Showing 6 of 12 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.